vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and MACERICH CO (MAC). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $261.7M, roughly 2.0× MACERICH CO). MACERICH CO runs the higher net margin — -7.2% vs -12.3%, a 5.2% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 12.0%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

The Macerich Company is a real estate investment trust that invests in shopping centers. It is the third-largest owner and operator of shopping centers in the United States. As of December 31, 2024, the company owned interests in 43 properties comprising 43 million square feet of leasable area. The company name is a portmanteau of its founders, Mace Siegel and Richard Cohen.

GENI vs MAC — Head-to-Head

Bigger by revenue
GENI
GENI
2.0× larger
GENI
$510.9M
$261.7M
MAC
Higher net margin
MAC
MAC
5.2% more per $
MAC
-7.2%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
12.0%
MAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
MAC
MAC
Revenue
$510.9M
$261.7M
Net Profit
$-63.0M
$-18.8M
Gross Margin
25.2%
Operating Margin
-11.5%
Net Margin
-12.3%
-7.2%
Revenue YoY
-4.4%
Net Profit YoY
91.1%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
MAC
MAC
Q4 25
$510.9M
$261.7M
Q3 25
$335.4M
$253.3M
Q2 25
$215.2M
$249.8M
Q1 25
$119.7M
$249.2M
Q4 24
$413.0M
$273.7M
Q3 24
$285.8M
$220.2M
Q2 24
$184.1M
$215.5M
Q1 24
$97.2M
$208.8M
Net Profit
GENI
GENI
MAC
MAC
Q4 25
$-63.0M
$-18.8M
Q3 25
$-87.4M
Q2 25
$-47.3M
$-40.9M
Q1 25
$-25.5M
$-50.1M
Q4 24
$-85.5M
$-211.2M
Q3 24
$-47.1M
$-108.2M
Q2 24
$-35.5M
$252.0M
Q1 24
$-25.2M
$-126.7M
Gross Margin
GENI
GENI
MAC
MAC
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Q1 24
9.8%
Operating Margin
GENI
GENI
MAC
MAC
Q4 25
-11.5%
Q3 25
-15.3%
Q2 25
-21.0%
Q1 25
-20.3%
Q4 24
-18.0%
Q3 24
-13.9%
Q2 24
-16.8%
Q1 24
-23.7%
Net Margin
GENI
GENI
MAC
MAC
Q4 25
-12.3%
-7.2%
Q3 25
-34.5%
Q2 25
-22.0%
-16.4%
Q1 25
-21.3%
-20.1%
Q4 24
-20.7%
-77.2%
Q3 24
-16.5%
-49.1%
Q2 24
-19.3%
116.9%
Q1 24
-25.9%
-60.7%
EPS (diluted)
GENI
GENI
MAC
MAC
Q4 25
$-0.08
Q3 25
$-0.34
Q2 25
$-0.16
Q1 25
$-0.20
Q4 24
$-0.95
Q3 24
$-0.50
Q2 24
$1.16
Q1 24
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
MAC
MAC
Cash + ST InvestmentsLiquidity on hand
$280.6M
$280.2M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$724.5M
$2.4B
Total Assets
$1.1B
$8.4B
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
MAC
MAC
Q4 25
$280.6M
$280.2M
Q3 25
$110.2M
$290.2M
Q2 25
$110.2M
$131.1M
Q1 25
$110.2M
$253.2M
Q4 24
$100.3M
$89.9M
Q3 24
$100.3M
$116.5M
Q2 24
$100.3M
$70.7M
Q1 24
$100.3M
$120.1M
Total Debt
GENI
GENI
MAC
MAC
Q4 25
$5.1B
Q3 25
$5.1B
Q2 25
$5.2B
Q1 25
$5.2B
Q4 24
$4.9B
Q3 24
$4.3B
Q2 24
$4.4B
Q1 24
$4.1B
Stockholders' Equity
GENI
GENI
MAC
MAC
Q4 25
$724.5M
$2.4B
Q3 25
$572.4M
$2.5B
Q2 25
$572.4M
$2.6B
Q1 25
$572.4M
$2.7B
Q4 24
$573.0M
$2.8B
Q3 24
$573.0M
$2.5B
Q2 24
$573.0M
$2.5B
Q1 24
$573.0M
$2.3B
Total Assets
GENI
GENI
MAC
MAC
Q4 25
$1.1B
$8.4B
Q3 25
$792.3M
$8.4B
Q2 25
$792.3M
$8.7B
Q1 25
$792.3M
$8.7B
Q4 24
$775.7M
$8.6B
Q3 24
$775.7M
$7.6B
Q2 24
$775.7M
$7.8B
Q1 24
$775.7M
$7.4B
Debt / Equity
GENI
GENI
MAC
MAC
Q4 25
2.07×
Q3 25
2.02×
Q2 25
2.02×
Q1 25
1.96×
Q4 24
1.78×
Q3 24
1.73×
Q2 24
1.75×
Q1 24
1.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
MAC
MAC
Operating Cash FlowLast quarter
$81.9M
$50.2M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
MAC
MAC
Q4 25
$81.9M
$50.2M
Q3 25
$-4.8M
$112.4M
Q2 25
$-1.2M
$70.5M
Q1 25
$-14.6M
$88.5M
Q4 24
$14.9M
$54.9M
Q3 24
$-9.2M
$100.0M
Q2 24
$67.4M
Q1 24
$61.1M
Free Cash Flow
GENI
GENI
MAC
MAC
Q4 25
$69.6M
Q3 25
$-14.2M
Q2 25
$-5.8M
Q1 25
$-16.0M
Q4 24
$11.3M
Q3 24
$-11.6M
Q2 24
Q1 24
FCF Margin
GENI
GENI
MAC
MAC
Q4 25
13.6%
Q3 25
-4.2%
Q2 25
-2.7%
Q1 25
-13.4%
Q4 24
2.7%
Q3 24
-4.1%
Q2 24
Q1 24
Capex Intensity
GENI
GENI
MAC
MAC
Q4 25
2.4%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
1.2%
Q4 24
0.9%
Q3 24
0.9%
Q2 24
Q1 24
Cash Conversion
GENI
GENI
MAC
MAC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons